Voquezna Triple Pak and Voquezna Dual Pak both treat helicobacter pylori and are supplied in blister packs.
A commercial launch is expected in the third quarter of 2022.
2 gastrointestinal drugs get FDA approval
Two drugs treating gastrointestinal illnesses have received FDA approval, Phathom Pharmaceuticals said May 3.
